Daniel M. Blumenthal, MD, MBA

home / authors / daniel-m-blumenthal-md-mba

Articles

June 15th 2016

Value of Improved Lipid Control in Patients at High Risk for Adverse Cardiac Events

Anupam B. Jena, MD, PhD Daniel M. Blumenthal, MD, MBA Warren Stevens, PhD Jacquelyn W. Chou, MPP, MPL Thanh G.N. Ton, PhD Dana P. Goldman, PhD

Reducing lipid levels in high-risk patients can significantly reduce disease burden and, depending on final negotiated prices, PCSK9 inhibitors can make an economic contribution to this goal.

February 11th 2013

Guidance for Structuring Team-Based Incentives in Healthcare

Daniel M. Blumenthal, MD, MBA Zirui Song, PhD Anupam B. Jena, MD, PhD Timothy G. Ferris, MD, MPH

Team-based performance incentives may improve healthcare team performance, but provider organizations face a number of structural, technical, and cultural barriers to adopting them.